Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 23, 2002
[Sentinel lymph node biopsy in breast cancer]Kunwei Shen, Lamichhane Nirmal, Qixia Han, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Decoding adipocyte heterogeneity through single-nucleus transcriptomics unveils subtype-specific adipocytes orchestrate immunosuppressive niches in breast cancerYiwei Tong, Zheng Wang, Niu Qiao, et al.
BMC Cancer|July 3, 2023
Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world studyYunjing Shi, Zeping Qiu, Jing Yu, et al.
Scientific Reports|September 13, 2019
21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph NodesYiwei Tong, Jiayi Wu, Ou Huang, et al.
The Oncologist|April 26, 2019
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based AnalysisShuning Ding, Jiayi Wu, Caijin Lin, et al.
Cancer Communications (London, England)|May 9, 2023
Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancerShuning Ding, Niu Qiao, Qingchen Zhu, et al.
Oncology Letters|July 30, 2020
Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26-30Jing Yu, Jiayi Wu, Ou Huang, et al.
Frontiers in Immunology|December 21, 2023
An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancerHan Wang, Ruo Wang, Lei Luo, et al.
Breast (Edinburgh, Scotland)|November 9, 2020
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumabShuai Li, Jiayi Wu, Ou Huang, et al.
American Journal of Cancer Research|January 12, 2022
Distribution and influence of the 21-gene recurrence score on chemotherapy decision-making in special type of breast cancerJing Yu, Jiayi Wu, Ou Huang, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 23, 2002
[Sentinel lymph node biopsy in breast cancer]Kunwei Shen, Lamichhane Nirmal, Qixia Han, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Decoding adipocyte heterogeneity through single-nucleus transcriptomics unveils subtype-specific adipocytes orchestrate immunosuppressive niches in breast cancerYiwei Tong, Zheng Wang, Niu Qiao, et al.
BMC Cancer|July 3, 2023
Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world studyYunjing Shi, Zeping Qiu, Jing Yu, et al.
Scientific Reports|September 13, 2019
21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph NodesYiwei Tong, Jiayi Wu, Ou Huang, et al.
The Oncologist|April 26, 2019
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based AnalysisShuning Ding, Jiayi Wu, Caijin Lin, et al.
Cancer Communications (London, England)|May 9, 2023
Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancerShuning Ding, Niu Qiao, Qingchen Zhu, et al.
Oncology Letters|July 30, 2020
Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26-30Jing Yu, Jiayi Wu, Ou Huang, et al.
Frontiers in Immunology|December 21, 2023
An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancerHan Wang, Ruo Wang, Lei Luo, et al.
Breast (Edinburgh, Scotland)|November 9, 2020
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumabShuai Li, Jiayi Wu, Ou Huang, et al.
American Journal of Cancer Research|January 12, 2022
Distribution and influence of the 21-gene recurrence score on chemotherapy decision-making in special type of breast cancerJing Yu, Jiayi Wu, Ou Huang, et al.
Pageof 21